SCHEMBL3846751

SCHEMBL3846751

Cc1ccc(-c2ccn(C(c3ccccc3)(c3ccccc3)c3ccccc3)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.44
NPC1 O15118 6/20 0.44
RAB9A P51151 6/20 0.44
SMN1; SMN2 Q16637 6/20 0.44
MAPT P10636 5/20 0.44
ALDH1A1 P00352 3/20 0.44
STAT1 P42224 1/20 0.44
MEN1 O00255 5/20 0.41
KDM4E B2RXH2 3/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
USP2 O75604 1/20 0.41
MAPK1 P28482 1/20 0.41
ATM Q13315 1/20 0.41
HPGD P15428 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
SLC2A1 P11166 1/20 0.39
ALDH1A3 P47895 1/20 0.39
KEAP1 Q14145 1/20 0.39
GAA P10253 1/20 0.38
LMNA P02545 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9089445 0.89 NPC1 (0.38) KMT2ANPC1RAB9ASMN1; SMN2MAPT
SCHEMBL5800759 0.88 KMT2A (0.52) KMT2ANPC1RAB9ASMN1; SMN2MAPT
SCHEMBL3845757 0.84 MAPT (0.42) KMT2ANPC1RAB9ASMN1; SMN2MAPT
SCHEMBL3847283 0.83 KIF11 (0.47) KMT2AALDH1A1KDM4ETSHRTP53
SCHEMBL9404829 0.82 DYRK1A (0.42) KMT2ANPC1RAB9ASMN1; SMN2MAPT
SCHEMBL9234564 0.80 KMT2A (0.38) KMT2ANPC1RAB9ASMN1; SMN2MAPT
SCHEMBL18528991 0.78 PDK2 (0.40) KMT2A
SCHEMBL3847017 0.78 MEN1 (0.47) KMT2ANPC1RAB9ASMN1; SMN2MAPT
SCHEMBL3846757 0.78 SCN5A (0.48) NPC1RAB9AMAPTALDH1A1KDM4E
SCHEMBL3791987 0.78 KEAP1 (0.44) KMT2ANPC1RAB9ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed
EP-0665223-A1 Antitumor agent, novel 3(2H)-pyridazinone derivatives and their preparation TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-08-02 EP disclosed